• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶3亚型在心肌中的功能。

Functions of PDE3 Isoforms in Cardiac Muscle.

作者信息

Movsesian Matthew, Ahmad Faiyaz, Hirsch Emilio

机构信息

Department of Internal Medicine/Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT 841132, USA.

Vascular Biology and Hypertension Branch, Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA.

出版信息

J Cardiovasc Dev Dis. 2018 Feb 6;5(1):10. doi: 10.3390/jcdd5010010.

DOI:10.3390/jcdd5010010
PMID:29415428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5872358/
Abstract

Isoforms in the PDE3 family of cyclic nucleotide phosphodiesterases have important roles in cyclic nucleotide-mediated signalling in cardiac myocytes. These enzymes are targeted by inhibitors used to increase contractility in patients with heart failure, with a combination of beneficial and adverse effects on clinical outcomes. This review covers relevant aspects of the molecular biology of the isoforms that have been identified in cardiac myocytes; the roles of these enzymes in modulating cAMP-mediated signalling and the processes mediated thereby; and the potential for targeting these enzymes to improve the profile of clinical responses.

摘要

环核苷酸磷酸二酯酶PDE3家族的同工型在心肌细胞中环核苷酸介导的信号传导中发挥重要作用。这些酶是用于增加心力衰竭患者心肌收缩力的抑制剂的作用靶点,对临床结局有有益和不良的综合影响。本综述涵盖了在心肌细胞中已鉴定出的同工型的分子生物学相关方面;这些酶在调节cAMP介导的信号传导及其介导的过程中的作用;以及靶向这些酶以改善临床反应情况的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/ae6c19924676/jcdd-05-00010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/5b9d908cbd2b/jcdd-05-00010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/ce72e828a01c/jcdd-05-00010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/31886b10d953/jcdd-05-00010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/ae6c19924676/jcdd-05-00010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/5b9d908cbd2b/jcdd-05-00010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/ce72e828a01c/jcdd-05-00010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/31886b10d953/jcdd-05-00010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e59/5872358/ae6c19924676/jcdd-05-00010-g004.jpg

相似文献

1
Functions of PDE3 Isoforms in Cardiac Muscle.磷酸二酯酶3亚型在心肌中的功能。
J Cardiovasc Dev Dis. 2018 Feb 6;5(1):10. doi: 10.3390/jcdd5010010.
2
Novel approaches to targeting PDE3 in cardiovascular disease.针对心血管疾病中 PDE3 的新型靶向方法。
Pharmacol Ther. 2016 Jul;163:74-81. doi: 10.1016/j.pharmthera.2016.03.014. Epub 2016 Apr 22.
3
PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes.磷酸二酯酶3(PDE3)环核苷酸磷酸二酯酶与心肌细胞中环核苷酸介导信号传导的区室化
Basic Res Cardiol. 2002;97 Suppl 1:I83-90. doi: 10.1007/s003950200035.
4
PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider.扩张型心肌病中磷酸二酯酶3的抑制作用:重新审视的理由
J Card Fail. 2003 Dec;9(6):475-80. doi: 10.1016/s1071-9164(03)00135-0.
5
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.心脏和血管中的环核苷酸磷酸二酯酶:治疗前景
Arch Cardiovasc Dis. 2016 Jun-Jul;109(6-7):431-43. doi: 10.1016/j.acvd.2016.02.004. Epub 2016 May 13.
6
Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.环核苷酸磷酸二酯酶3和5抑制剂作为心力衰竭的治疗药物
Expert Opin Investig Drugs. 2006 Jul;15(7):733-42. doi: 10.1517/13543784.15.7.733.
7
[Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].[环核苷酸磷酸二酯酶:在心脏中的作用及治疗前景]
Biol Aujourdhui. 2016;210(3):127-138. doi: 10.1051/jbio/2016019. Epub 2016 Nov 4.
8
Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.利钠肽通过抑制磷酸二酯酶 3 增加衰竭心脏中的β1-肾上腺素能受体信号传导。
Cardiovasc Res. 2010 Mar 1;85(4):763-72. doi: 10.1093/cvr/cvp364. Epub 2009 Nov 9.
9
Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy.环核苷酸磷酸二酯酶PDE3抑制剂作为扩张型心肌病的辅助治疗手段
Expert Opin Investig Drugs. 2002 Nov;11(11):1529-36. doi: 10.1517/13543784.11.11.1529.
10
Phosphodiesterase type 3A (PDE3A), but not type 3B (PDE3B), contributes to the adverse cardiac remodeling induced by pressure overload.磷酸二酯酶 3A 型(PDE3A),而不是 3B 型(PDE3B),有助于压力超负荷引起的不良心脏重构。
J Mol Cell Cardiol. 2019 Jul;132:60-70. doi: 10.1016/j.yjmcc.2019.04.028. Epub 2019 Apr 30.

引用本文的文献

1
Establishing a context of use for three-dimensional cardiac tissue derived from human-induced pluripotent stem cell-derived cardiomyocytes using inotropes.利用变力性药物建立源自人诱导多能干细胞衍生心肌细胞的三维心脏组织的使用背景。
Toxicol Sci. 2025 Jun 1;205(2):401-416. doi: 10.1093/toxsci/kfaf033.
2
Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure.磷酸二酯酶4家族在心肌细胞生理学和心力衰竭中的作用
Cells. 2025 Mar 20;14(6):460. doi: 10.3390/cells14060460.
3
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.

本文引用的文献

1
PI3K and Calcium Signaling in Cardiovascular Disease.PI3K 与心血管疾病中的钙信号转导。
Circ Res. 2017 Jul 21;121(3):282-292. doi: 10.1161/CIRCRESAHA.117.310183.
2
A PDE3A mutation in familial hypertension and brachydactyly syndrome.家族性高血压和短指综合征中的磷酸二酯酶3A(PDE3A)突变
J Hum Genet. 2016 Aug;61(8):701-3. doi: 10.1038/jhg.2016.32. Epub 2016 Apr 7.
3
Design and discovery of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives as cardiotonic agents via inhibition of PDE3.通过抑制磷酸二酯酶3(PDE3)设计并发现2-(4-(1H-四唑-5-基)-1H-吡唑-1-基)-4-(4-苯基)噻唑衍生物作为强心剂
新兴的抗炎性 COPD 治疗方法:潜在的心血管影响。
Int J Chron Obstruct Pulmon Dis. 2024 Nov 21;19:2481-2495. doi: 10.2147/COPD.S498255. eCollection 2024.
4
Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability.依诺昔酮/羟丙基-β-环糊精包合物气雾剂,急性呼吸窘迫综合征适用性的生物制药证据。
Pharmaceutics. 2024 Sep 19;16(9):1221. doi: 10.3390/pharmaceutics16091221.
5
Exosomal Preconditioning of Human iPSC-Derived Cardiomyocytes Beneficially Alters Cardiac Electrophysiology and Micro RNA Expression.人诱导多能干细胞衍生心肌细胞的外泌体预处理有益于改变心脏电生理学和 microRNA 表达。
Int J Mol Sci. 2024 Aug 2;25(15):8460. doi: 10.3390/ijms25158460.
6
Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.心脏病理生理学中的纳米域环磷酸腺苷信号传导:开发靶向治疗干预措施的潜力
Physiol Rev. 2025 Apr 1;105(2):541-591. doi: 10.1152/physrev.00013.2024. Epub 2024 Aug 8.
7
Differential Downregulation of β-Adrenergic Receptor Signaling in the Heart.β-肾上腺素能受体信号在心脏中的差异下调。
J Am Heart Assoc. 2024 Jun 18;13(12):e033733. doi: 10.1161/JAHA.123.033733. Epub 2024 Jun 11.
8
Administration of Liposomal-Based Gene Therapy Protects Mice Against Collagen-Induced Rheumatoid Arthritis via Modulating Macrophage Polarization.脂质体基因治疗可通过调节巨噬细胞极化来保护小鼠免受胶原诱导的类风湿关节炎。
Int J Nanomedicine. 2024 May 17;19:4411-4427. doi: 10.2147/IJN.S454445. eCollection 2024.
9
The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection.环磷酸腺苷/环磷酸鸟苷信号传导及环核苷酸磷酸二酯酶在主动脉瘤和主动脉夹层中的研究视角
Vascul Pharmacol. 2024 Mar;154:107278. doi: 10.1016/j.vph.2024.107278. Epub 2024 Jan 21.
10
Phosphodiesterase in heart and vessels: from physiology to diseases.心脏和血管中的磷酸二酯酶:从生理学到疾病。
Physiol Rev. 2024 Apr 1;104(2):765-834. doi: 10.1152/physrev.00015.2023. Epub 2023 Nov 16.
Bioorg Med Chem. 2015 Sep 15;23(18):6111-7. doi: 10.1016/j.bmc.2015.08.002. Epub 2015 Aug 7.
4
Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly.磷酸二酯酶3A突变在遗传性高血压伴短指症中的临床效应
Hypertension. 2015 Oct;66(4):800-8. doi: 10.1161/HYPERTENSIONAHA.115.06000. Epub 2015 Aug 17.
5
Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.磷酸二酯酶 2 调控的局部环腺苷酸池抑制心肌肥厚。
Circ Res. 2015 Sep 25;117(8):707-19. doi: 10.1161/CIRCRESAHA.114.305892. Epub 2015 Aug 4.
6
The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin.磷酸二酯酶3B(PDE3B)磷酸化在胰岛素抑制脂肪分解中的作用
Mol Cell Biol. 2015 Aug;35(16):2752-60. doi: 10.1128/MCB.00422-15. Epub 2015 Jun 1.
7
PDE3A mutations cause autosomal dominant hypertension with brachydactyly.PDE3A 突变导致常染色体显性遗传性高血压伴短指(趾)畸形。
Nat Genet. 2015 Jun;47(6):647-53. doi: 10.1038/ng.3302. Epub 2015 May 11.
8
Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.特异性破坏磷酸二酯酶3B(PDE3B)而非磷酸二酯酶3A(PDE3A)可保护小鼠心脏免受缺血/再灌注损伤。
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2253-62. doi: 10.1073/pnas.1416230112. Epub 2015 Apr 15.
9
Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.磷酸二酯酶3A(PDE3A)对人心肌肌浆网Ca2+ ATP酶2(SERCA2)活性的调节:PDE3A1与SERCA2的磷酸化依赖性相互作用
J Biol Chem. 2015 Mar 13;290(11):6763-76. doi: 10.1074/jbc.M115.638585. Epub 2015 Jan 15.
10
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive.联合抑制 PI3Kβ 和 PI3Kγ 通过增强 α-MSH 依赖性交感神经驱动来减少脂肪量。
Sci Signal. 2014 Nov 18;7(352):ra110. doi: 10.1126/scisignal.2005485.